Volume Analysis
Futures
SPOT Pivot Levels
| Type | Classic | Fibonacci |
|---|---|---|
| R1 | 5,028 | 5,002.81 |
| R2 | 5,085 | 5,034.19 |
| R3 | 5,161 | 5,085 |
| PP | 4,952 | 4,952 |
| S1 | 5,028 | 5,002.81 |
| S2 | 4,819 | 4,869.81 |
| S3 | 4,762 | 4,819 |
Ratios
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| ROCE | - | 13.43 | - | 28.21 | - |
| ROE | - | 24.07 | - | 24.92 | - |
| EPS | 12.94 | 7.74 | 17.04 | 17.64 | 16.28 |
Peer Comparison
| Scrip Name | Price | Daily change | M Cap | PE Ratio | 1 Year Return |
|---|---|---|---|---|---|
| No data available | |||||
Corporate Action
- Announcements
- Board Meetings
- Dividends
- Bonus
- Splits
- Rights
- AGM/EGM
- Credit Rating
About Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Limited is a leading player in the Indian pharmaceutical sector, concentrating on the chronic and sub-chronic therapeutic segments. The Company has established itself as a leader in developing niche pharmaceutical solutions through its patient-centric innovation. The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), ...
ISIN :INE685A01028
Registered Office
Torrent House,Off Ashram Road
Contact number
+ 91-79-26599000
Registrars
KFin Techologies Ltd
Karvy Selenium Tow-B 31&32 Financial Dist Nanakramguda Hyderabad-500032
Karvy Selenium Tow-B 31&32 Financial Dist Nanakramguda Hyderabad-500032
Contact number
+ 91-40-67162222
Management
Sudhir Mehta (Chairman)
Open IPO’s
Price Range
₹152 - ₹160
Min. Quantity
93 Shares
Min. investment
₹14,880
Closes on
August 21, 2026
Price Range
₹342 - ₹360
Min. Quantity
41 Shares
Min. investment
₹14,760
Closes on
August 20, 2026
Price Range
₹88 - ₹93
Min. Quantity
160 Shares
Min. investment
₹14,880
Closes on
August 20, 2026
Price Range
₹190 - ₹201
Min. Quantity
74 Shares
Min. investment
₹14,874
Closes on
August 19, 2026
Price Range
₹57 - ₹60
Min. Quantity
250 Shares
Min. investment
₹15,000
Closes on
August 19, 2026
FAQs
The share price of Torrent Pharmaceuticals Ltd on the BSE is - as on -